Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.1650
+0.0300 (22.22%)
May 1, 2026, 3:58 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 25.33 million as of May 1, 2026. Its market cap has increased by 19.51% in one year.
Market Cap
25.33M
Enterprise Value
27.61M
Revenue
175.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 25.33M, an increase of 271.20%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 25.33M | 7.54% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theralase Technologies | 107.52M |
| Cannabix Technologies | 92.13M |
| Perimeter Medical Imaging AI | 42.88M |
| Conavi Medical | 41.40M |
| Cheelcare | 35.60M |
| Aurora Spine | 21.30M |
| Frequency Exchange | 18.59M |
| MedX Health | 18.04M |